IDO1 and breast carcinoma: IDO-1 appeared only once among our included breast cancer articles, in a study where researchers analyzed the immunogenomic profiling and pathological response to neoadjuvant therapy including docetaxel and carboplatin, both commonly used in the treatment for breast cancer.